AAAAAA

   
Results: 1-7 |
Results: 7
The orphan nuclear receptor SXR coordinately regulates drug metabolism andefflux
Authors: Synold, TW Dussault, I Forman, BM
Citation: Tw. Synold et al., The orphan nuclear receptor SXR coordinately regulates drug metabolism andefflux, NAT MED, 7(5), 2001, pp. 584-590
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
Authors: Tetef, ML Synold, TW Chow, W Leong, L Margolin, K Morgan, R Raschko, J Shibata, S Somlo, G Yen, Y Groshen, S Johnson, K Lenz, HJ Gandara, D Doroshow, JH
Citation: Ml. Tetef et al., Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies, CLIN CANC R, 7(6), 2001, pp. 1569-1576
Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium
Authors: Margolin, K Longmate, J Synold, TW Gandara, DR Weber, J Gonzalez, R Johansen, MJ Newman, R Baratta, T Doroshow, JH
Citation: K. Margolin et al., Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium, INV NEW DR, 19(4), 2001, pp. 335-340
Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR
Authors: Dussault, I Lin, M Hollister, K Wang, EH Synold, TW Forman, BM
Citation: I. Dussault et al., Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR, J BIOL CHEM, 276(36), 2001, pp. 33309-33312
Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin
Authors: Doroshow, JH Synold, TW Somlo, G Akman, SA Gajewski, E
Citation: Jh. Doroshow et al., Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin, BLOOD, 97(9), 2001, pp. 2839-2845
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034
Authors: McLeod, HL Cassidy, J Powrie, RH Priest, DG Zorbas, MA Synold, TW Shibata, S Spicer, D Bissett, D Pithavala, YK Collier, MA Paradiso, LJ Roberts, JD
Citation: Hl. Mcleod et al., Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034, CLIN CANC R, 6(7), 2000, pp. 2677-2684
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A
Authors: Raschko, JW Synold, TW Chow, W Coluzzi, P Hamasaki, V Leong, LA Margolin, KA Morgan, RJ Shibata, SI Somlo, G Tetef, ML Yen, Y ter Veer, A Doroshow, JH
Citation: Jw. Raschko et al., A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A, CANC CHEMOT, 46(5), 2000, pp. 403-410
Risultati: 1-7 |